Affiliations 

  • 1 Centre for Epidemiological Studies and Clinical Trials, The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
  • 2 Philippine Heart Association, Dr. HB Calleja Heart and Vascular Institute, St. Luke's Medical Center, Metro Manila, Philippines
  • 3 Department of Medical Sciences, School of Healthcare and Medical Sciences, Sunway University, Selangor, Malaysia
  • 4 Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Shimotsuke, Japan
  • 5 Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan
  • 6 Division of Cardiology, Department of Internal Medicine, Yonsei University Health System, Seoul, Korea
  • 7 Bangkok Hospital Chiang Mai, Chiang Mai, Thailand
  • 8 General Medicine, Tan Tock Seng Hospital, Singapore City, Singapore
  • 9 Department of Neurology, Faculty of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia
  • 10 Asia Pacific Society of Hypertension, Department of Physiology, King George's Medical University, Lucknow, India
  • 11 Cardiovascular Center and Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan
  • 12 Tohoku Institute for Management of Blood Pressure, Sendai, Japan
J Clin Hypertens (Greenwich), 2021 Jan;23(1):3-11.
PMID: 33043574 DOI: 10.1111/jch.14074

Abstract

Hypertension is one of the most powerful modifiable risk factors for cardiovascular disease. It is usually asymptomatic and therefore essential to measure blood pressure regularly for the detection of hypertension. Home blood pressure monitoring (HBPM) is recognized as a valuable tool to monitor blood pressure and facilitate effective diagnosis of hypertension. It is useful to identify the masked or white-coat hypertension. There is also increasing evidence that supports the role of HBPM in guiding antihypertensive treatment, and improving treatment compliance and hypertension control. In addition, HBPM has also shown prognostic value in predicting cardiovascular events. Despite these benefits, the use of HBPM in many parts of Asia has been reported to be low. An expert panel comprising 12 leading experts from 10 Asian countries/regions convened to share their perspectives on the realities of HBPM. This article provides an expert summary of the current status of HBPM and the key factors hindering its use. It also describes HBPM-related initiatives in the respective countries/regions and presents strategies that could be implemented to better support the use of HBPM in the management of hypertension.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.